The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ARCA BIOPHARMA INC | COM NEW | 00211Y209 | 6,530 | 5,678,592 | SH | SOLE | 5,678,592 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 1,143 | 27,300 | SH | SOLE | 27,300 | 0 | 0 | ||
ACHILLION PHARMACEUTICALS INC | COM | 00448Q201 | 88,122 | 9,945,997 | SH | SOLE | 9,945,997 | 0 | 0 | ||
AGENUS INC | COM NEW | 00847G705 | 13,808 | 1,600,000 | SH | SOLE | 1,600,000 | 0 | 0 | ||
AGILE THERAPEUTICS INC | COM | 00847L100 | 12,531 | 1,458,792 | SH | SOLE | 1,458,792 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 1,100 | 9,900 | SH | SOLE | 9,900 | 0 | 0 | ||
ALCOBRA LTD | SHS | M2239P109 | 9,979 | 1,525,894 | SH | SOLE | 1,525,894 | 0 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 1,235 | 19,200 | SH | SOLE | 19,200 | 0 | 0 | ||
AMGEN INC | COM | 031162100 | 906 | 5,900 | SH | SOLE | 5,900 | 0 | 0 | ||
ARDELYX INC | COM | 039697107 | 27,468 | 1,719,945 | SH | SOLE | 1,719,945 | 0 | 0 | ||
ARRAY BIOPHARMA INC | COM | 04269X105 | 909 | 126,095 | SH | SOLE | 126,095 | 0 | 0 | ||
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 33,825 | 1,913,153 | SH | SOLE | 1,913,153 | 0 | 0 | ||
AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 3,451 | 1,142,676 | SH | SOLE | 1,142,676 | 0 | 0 | ||
AURIS MED HLDG AG | COM | H03579101 | 4,568 | 940,000 | SH | SOLE | 940,000 | 0 | 0 | ||
AXOVANT SCIENCES LTD | COM | G0750W104 | 101,900 | 5,000,000 | SH | SOLE | 5,000,000 | 0 | 0 | ||
BELLICUM PHARMACEUTICALS INC | COM | 079481107 | 21,832 | 1,026,402 | SH | SOLE | 1,026,402 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS | COM | 09058V103 | 38,898 | 2,605,361 | SH | SOLE | 2,605,361 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 1,050 | 2,600 | SH | SOLE | 2,600 | 0 | 0 | ||
BIOTA PHARMACEUTIALS INC | COM | 090694100 | 1,672 | 807,855 | SH | SOLE | 807,855 | 0 | 0 | ||
BLUEBIRD BIO INC | COM | 09609G100 | 18,417 | 109,383 | SH | SOLE | 109,383 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 23,267 | 878,348 | SH | SOLE | 878,348 | 0 | 0 | ||
CELGENE CORP | COM | 151020104 | 1,007 | 8,700 | SH | SOLE | 8,700 | 0 | 0 | ||
CIDARA THERAPEUTICS INC | COM | 171757107 | 16,001 | 1,141,333 | SH | SOLE | 1,141,333 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 1,160 | 13,200 | SH | SOLE | 13,200 | 0 | 0 | ||
COHERUS BIOSCIENCES INC | COM | 19249H103 | 39,891 | 1,380,320 | SH | SOLE | 1,380,320 | 0 | 0 | ||
COLLEGIUM PHARMACEUTICAL INC | COM | 19459J104 | 27,570 | 1,545,410 | SH | SOLE | 1,545,410 | 0 | 0 | ||
CONCERT PHARMACEUTICALS INC | COM | 206022105 | 9,953 | 668,406 | SH | SOLE | 668,406 | 0 | 0 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 33,879 | 2,428,571 | SH | SOLE | 2,428,571 | 0 | 0 | ||
DURECT CORP | COM | 266605104 | 913 | 381,800 | SH | SOLE | 381,800 | 0 | 0 | ||
DYAX CORP | COM | 26746E103 | 71,632 | 2,703,093 | SH | SOLE | 2,703,093 | 0 | 0 | ||
DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | 17,944 | 766,000 | SH | SOLE | 766,000 | 0 | 0 | ||
INCYTE CORP | COM | 45337C102 | 1,115 | 10,700 | SH | SOLE | 10,700 | 0 | 0 | ||
JUNO THERAPEUTICS INC | COM | 48205A109 | 14,932 | 280,000 | SH | SOLE | 280,000 | 0 | 0 | ||
KERYX BIOPHARMACEUTICALS INC | COM | 492515101 | 591 | 59,200 | SH | SOLE | 59,200 | 0 | 0 | ||
MEDICINES CO | COM | 584688105 | 20,197 | 705,925 | SH | SOLE | 705,925 | 0 | 0 | ||
MERRIMACK PHARMACEUTICALS IN | COM | 590328100 | 1,439 | 116,400 | SH | SOLE | 116,400 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 1,165 | 24,400 | SH | SOLE | 24,400 | 0 | 0 | ||
NEWLINK GENETICS CORP | COM | 651511107 | 1,328 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
NIVALIS THERAPEUTICS INC | COM | 65481J109 | 11,473 | 757,263 | SH | SOLE | 757,263 | 0 | 0 | ||
NOVAVAX INC | COM | 670002104 | 15,944 | 1,431,232 | SH | SOLE | 1,431,232 | 0 | 0 | ||
OMEROS CORP | COM | 682143102 | 13,475 | 749,000 | SH | SOLE | 749,000 | 0 | 0 | ||
PROTEON THERAPEUTICS INC | COM | 74371L109 | 26,913 | 1,506,872 | SH | SOLE | 1,506,872 | 0 | 0 | ||
PTC THERAPEUTICS INC | COM | 69366J200 | 1,242 | 25,800 | SH | SOLE | 25,800 | 0 | 0 | ||
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 362 | 3,100 | SH | SOLE | 3,100 | 0 | 0 | ||
REGENERON PHARMACEUTICALS | COM | 75886F107 | 1,250 | 2,450 | SH | SOLE | 2,450 | 0 | 0 | ||
REGULUS THERAPEUTICS INC | COM | 75915K101 | 41,544 | 3,790,476 | SH | SOLE | 3,790,476 | 0 | 0 | ||
SANGAMO BIOSCIENCES INC | COM | 800677106 | 13,532 | 1,220,209 | SH | SOLE | 1,220,209 | 0 | 0 | ||
SANGAMO BIOSCIENCES INC | COM | 800677106 | 66,540 | 6,000,000 | SH | Call | SOLE | 0 | 0 | 0 | |
SERES THERAPEUTICS INC | COM | 81750R102 | 10,236 | 246,645 | SH | SOLE | 246,645 | 0 | 0 | ||
SUCAMPO PHARMACEUTICALS INC | CL A | 864909106 | 7,394 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
T2 BIOSYSTEMS INC | COM | 89853L104 | 2,240 | 138,002 | SH | SOLE | 138,002 | 0 | 0 | ||
TENAX THERAPEUTICS INC | COM | 88032L100 | 9,853 | 2,670,300 | SH | SOLE | 2,670,300 | 0 | 0 | ||
TESARO INC | COM | 881569107 | 1,382 | 23,500 | SH | SOLE | 23,500 | 0 | 0 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | 54,784 | 3,302,213 | SH | SOLE | 3,302,213 | 0 | 0 | ||
THERAPEUTICSMD INC | COM | 88338N107 | 13,208 | 1,680,395 | SH | SOLE | 1,680,395 | 0 | 0 | ||
TREVENA INC | COM | 89532E109 | 3,306 | 528,118 | SH | SOLE | 528,118 | 0 | 0 | ||
VICAL INC | COM | 925602104 | 1,825 | 2,606,978 | SH | SOLE | 2,606,978 | 0 | 0 | ||
WAFERGEN BIO-SYSTEMS INC | COM PAR$ | 93041P308 | 647 | 205,400 | SH | SOLE | 205,400 | 0 | 0 | ||
XENCOR INC | COM | 98401F105 | 23,627 | 1,075,410 | SH | SOLE | 1,075,410 | 0 | 0 |